Cost-effectiveness analysis of cadonilimab combined with chemotherapy as first-line treatment for HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma
Health Systems, Economic Evaluations, Quality of Life
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Cost-effectiveness analysis of cadonilimab combined with chemotherapy as first-line treatment for HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma
Pan-Feng Feng, LongXun Zhu, Yong Chen, Shaoqing Zhan et al.
Journal
BMC Health Services Research
Topics
Health Systems, Economic Evaluations, Quality of Life
article
Cost-effectiveness analysis of cadonilimab combined with chemotherapy as first-line treatment for HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma
Pan-Feng Feng, LongXun Zhu, Yong Chen, Shaoqing Zhan, Lian Tang
article en
Abstract
No abstract available for this paper.
Publication Tag
BMC Health Services Research
Institutions
Nantong University (CN), Affiliated Hospital of Nantong University (CN), Second People's Hospital of NanTong (CN)
OpenAlex Percentile
Openalex Percentile: Top 10%
Topics
Health Systems, Economic Evaluations, Quality of Life